Daily Stock Analysis, GASX, Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics, Inc. was founded in 2000 and is based in Norcross, Georgia., priceseries

Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics, Inc. was founded in 2000 and is based in Norcross, Georgia.. Daily Stock Analysis
Stock Information
Open
14.71
Close
16.00
High
16.00
Low
14.42
Previous Close
13.37
Daily Price Gain
2.63
YTD High
49.91
YTD High Date
Mar 12, 2020
YTD Low
3.72
YTD Low Date
Jan 7, 2020
YTD Price Change
11.71
YTD Gain
272.79%
52 Week High
49.91
52 Week High Date
Mar 12, 2020
52 Week Low
3.64
52 Week Low Date
Sep 16, 2019
52 Week Price Change
11.47
52 Week Gain
253.20%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
May 24. 2017
3.09
Jun 12. 2017
3.67
12 Trading Days
18.60%
Link
LONG
Jun 14. 2017
3.82
Jun 23. 2017
4.18
7 Trading Days
9.48%
Link
LONG
Aug 2. 2017
3.65
Aug 23. 2017
4.19
15 Trading Days
14.72%
Link
LONG
Jan 29. 2018
2.02
Feb 15. 2018
2.84
13 Trading Days
40.74%
Link
LONG
Aug 7. 2018
1.76
Aug 21. 2018
1.89
10 Trading Days
7.58%
Link
LONG
Oct 17. 2018
1.87
Nov 1. 2018
2.53
11 Trading Days
35.16%
Link
LONG
Nov 12. 2018
2.68
Dec 3. 2018
2.99
14 Trading Days
11.54%
Link
LONG
Dec 4. 2018
3.15
Dec 26. 2018
5.16
14 Trading Days
63.53%
Link
LONG
Feb 5. 2019
3.23
Feb 13. 2019
3.42
6 Trading Days
5.86%
Link
LONG
Apr 25. 2019
2.75
May 10. 2019
3.17
11 Trading Days
15.54%
Link
LONG
May 22. 2019
3.51
Jun 18. 2019
4.70
18 Trading Days
34.17%
Link
LONG
Jul 15. 2019
4.80
Jul 30. 2019
5.54
11 Trading Days
15.34%
Link
LONG
Aug 1. 2019
6.44
Aug 19. 2019
7.61
12 Trading Days
18.22%
Link
LONG
Sep 24. 2019
5.32
Oct 23. 2019
7.64
21 Trading Days
43.74%
Link
LONG
Jan 16. 2020
4.53
Feb 5. 2020
7.05
13 Trading Days
55.58%
Link
LONG
Feb 21. 2020
8.43
Mar 13. 2020
25.06
15 Trading Days
197.40%
Link
Company Information
Stock Symbol
GASX
Exchange
NASDAQ
Company URL
http://www.galectintherapeutics.com
Company Phone
678-620-3186
CEO
Peter G. Traber
Headquarters
Georgia
Business Address
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA 30071
Sector
Equity
Industry Category
Drugs
Industry Group
Drugs - Generic
CIK
0001133416
About

Galectin Therapeutics, Inc. operates as a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease and cancer. Its drug candidates are based on the method of targeting galectin proteins, which are key mediators of biologic and pathologic function and its focus is on diseases with serious, life-threatening consequences to patients and those where current treatment options are limited. The company was founded by James C. Czirr and Anatole A. Kltyosov on July 10, 2000 and is headquartered in Norcross, GA.

Description

Galectin Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic disease and cancer. The company's lead product candidate includes galectin-3 inhibitor (GR-MD-02), a galactoarabino-rhamnogalacturonan polysaccharide polymer for the treatment of liver fibrosis and liver cirrhosis in non-alcoholic steatohepatitis patients, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development state for the treatment of cardiac and vascular fibrosis, as well as focuses on developing GR-MD-02 for the treatment of psoriasis. The company, through its collaborative joint venture, Galectin Sciences, LLC with SBH Sciences, Inc., is also involved in the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics, Inc. was founded in 2000 and is based in Norcross, Georgia.